Literature DB >> 30723528

RE: "An Estimation of the Risk of Pseudotumor Cerebri Among Users of the Levonorgestrel Intrauterine Device".

Asieh Golozar1, Juliane Schoendorf2.   

Abstract

The current letter to the editor describes some of the limitations of Valenzuela et al.'s study on the association between levonorgestrel-releasing intrauterine system use and pseudotumor cerebri/idiopathic intracranial hypertension and further reinforces the authors' interpretations of the findings.

Entities:  

Keywords:  Pseudotumor cerebri; contraception; idiopathic intracranial hypertension; levonorgestrel intrauterine system; prevalence

Year:  2018        PMID: 30723528      PMCID: PMC6351020          DOI: 10.1080/01658107.2018.1465439

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  7 in total

Review 1.  Idiopathic intracranial hypertension.

Authors:  Alex K Ball; Carl E Clarke
Journal:  Lancet Neurol       Date:  2006-05       Impact factor: 44.182

2.  Contraceptive use in the Nordic countries.

Authors:  Ingela Lindh; Finn E Skjeldestad; Kristina Gemzell-Danielsson; Oskari Heikinheimo; Helena Hognert; Ian Milsom; Øjvind Lidegaard
Journal:  Acta Obstet Gynecol Scand       Date:  2017-01       Impact factor: 3.636

3.  Women's contraceptive practices and sexual behaviour in Europe.

Authors:  David Cibula
Journal:  Eur J Contracept Reprod Health Care       Date:  2008-12       Impact factor: 1.848

4.  Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015.

Authors:  Sheree L Boulet; Denise V D'Angelo; Brian Morrow; Lauren Zapata; Erin Berry-Bibee; Maria Rivera; Sascha Ellington; Lisa Romero; Eva Lathrop; Meghan Frey; Tanya Williams; Howard Goldberg; Lee Warner; Leslie Harrison; Shanna Cox; Karen Pazol; Wanda Barfield; Denise J Jamieson; Margaret A Honein; Charlan D Kroelinger
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-05       Impact factor: 17.586

5.  An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device.

Authors:  Reuben M Valenzuela; Ruju Rai; Brian H Kirk; Jessica N Sanders; Subhashree Sundar; Steffen Hamann; Judith E A Warner; Kathleen B Digre; Alison V Crum; Kirtly P Jones; Bradley J Katz
Journal:  Neuroophthalmology       Date:  2017-04-19

6.  Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15-44: United States, 2011-2013.

Authors:  Kimberly Daniels; Jill Daugherty; Jo Jones; William Mosher
Journal:  Natl Health Stat Report       Date:  2015-11-10

7.  Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.

Authors:  Jessica N Sanders; David K Turok; Lori M Gawron; Amy Law; Lonnie Wen; Richard Lynen
Journal:  Am J Obstet Gynecol       Date:  2017-02-08       Impact factor: 8.661

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.